O	O	O	0	1	A	A	B-NP	DT	O	7	NMOD	O
O	O	O	2	7	novel	novel	I-NP	JJ	O	7	NMOD	O
T6	B-Entity	B-Entity	8	11	Ets	Ets	I-NP	NN	B-protein	7	NMOD	B-protein
O	O	O	11	12	-	-	B-NP	HYPH	O	7	NMOD	O
O	O	O	12	19	related	relate	I-NP	VBN	O	7	NMOD	O
O	O	O	20	33	transcription	transcription	I-NP	NN	B-protein	7	NMOD	B-protein
O	O	O	34	40	factor	factor	I-NP	NN	I-protein	10	NMOD	I-protein
O	O	O	40	41	,	,	O	,	O	10	P	O
T1	B-Protein	B-Protein	42	45	Elf	Elf	B-NP	NN	B-protein	10	NMOD	B-protein
T1	I-Protein	I-Protein	45	46	-	-	B-NP	HYPH	I-protein	13	SUB	I-protein
T1	I-Protein	I-Protein	46	47	1	1	I-NP	CD	I-protein	10	NMOD	I-protein
O	O	O	47	48	,	,	O	,	O	10	P	O
O	O	O	49	54	binds	bind	B-VP	VBZ	O	0	ROOT	O
O	O	O	55	57	to	to	B-PP	TO	O	13	VMOD	O
T7	B-Entity	B-Entity	58	63	human	human	B-NP	JJ	B-DNA	21	NMOD	B-DNA
T7	I-Entity	I-Entity	64	80	immunodeficiency	immunodeficiency	I-NP	NN	I-DNA	21	NMOD	I-DNA
T7	I-Entity	I-Entity	81	86	virus	virus	I-NP	NN	I-DNA	21	NMOD	I-DNA
T7	I-Entity	I-Entity	87	91	type	type	I-NP	NN	I-DNA	21	NMOD	I-DNA
T7	I-Entity	I-Entity	92	93	2	2	I-NP	CD	I-DNA	21	NMOD	I-DNA
T7	I-Entity	I-Entity	94	104	regulatory	regulatory	I-NP	JJ	I-DNA	21	NMOD	I-DNA
T7	I-Entity	I-Entity	105	113	elements	element	I-NP	NNS	I-DNA	14	PMOD	I-DNA
O	O	O	114	118	that	that	B-NP	WDT	O	21	NMOD	O
O	O	O	119	122	are	be	B-VP	VBP	O	22	SBAR	O
O	O	O	123	131	required	require	I-VP	VBN	O	23	VC	O
O	O	O	132	135	for	for	B-PP	IN	O	24	VMOD	O
O	O	O	136	145	inducible	inducible	B-NP	JJ	O	28	NMOD	O
O	O	O	146	151	trans	trans	I-NP	JJ	O	28	NMOD	O
O	O	O	152	162	activation	activation	I-NP	NN	O	25	PMOD	O
O	O	O	163	165	in	in	B-PP	IN	O	28	NMOD	O
O	O	O	166	167	T	T	B-NP	NN	B-cell_type	31	NMOD	B-cell_type
O	O	O	168	173	cells	cell	I-NP	NNS	I-cell_type	29	PMOD	I-cell_type
O	O	O	173	174	.	.	O	.	O	13	P	O

O	O	O	176	181	Human	Human	B-NP	JJ	O	4	NMOD	O
O	O	O	182	198	immunodeficiency	immunodeficiency	I-NP	NN	O	4	NMOD	O
O	O	O	199	204	virus	virus	I-NP	NN	O	4	NMOD	O
O	O	O	205	209	type	type	I-NP	NN	O	15	SUB	O
O	O	O	210	211	1	1	I-NP	CD	O	4	NMOD	O
O	O	O	212	213	(	(	O	(	O	10	DEP	O
O	O	O	213	216	HIV	HIV	B-NP	NN	O	9	SUB	O
O	O	O	216	217	-	-	B-NP	HYPH	O	9	P	O
O	O	O	217	218	1	1	I-NP	CD	O	10	DEP	O
O	O	O	218	219	)	)	O	)	O	4	NMOD	O
O	O	O	220	223	and	and	O	CC	O	15	VMOD	O
O	O	O	224	227	HIV	HIV	B-NP	NN	O	15	SUB	O
O	O	O	227	228	-	-	O	HYPH	O	12	P	O
O	O	O	228	229	2	2	B-NP	CD	O	12	NMOD	O
O	O	O	230	233	are	be	B-VP	VBP	O	0	ROOT	O
O	O	O	234	246	structurally	structurally	B-NP	RB	O	17	AMOD	O
O	O	O	247	254	related	relate	I-NP	VBN	O	18	NMOD	O
O	O	O	255	267	retroviruses	retrovirus	I-NP	NNS	O	15	PRD	O
O	O	O	268	273	which	which	B-NP	WDT	O	18	NMOD	O
O	O	O	274	278	both	both	O	DT	O	21	VMOD	O
O	O	O	279	284	cause	cause	B-VP	VBP	O	19	SBAR	O
O	O	O	285	289	AIDS	AIDS	B-NP	NN	O	21	OBJ	O
O	O	O	290	292	in	in	B-PP	IN	O	21	VMOD	O
O	O	O	293	299	humans	human	B-NP	NNS	O	23	PMOD	O
O	O	O	299	300	.	.	O	.	O	15	P	O

O	O	O	301	309	Although	Although	B-SBAR	IN	O	24	VMOD	O
O	O	O	310	314	both	both	B-NP	DT	O	3	NMOD	O
O	O	O	315	322	viruses	virus	I-NP	NNS	O	4	SUB	O
O	O	O	323	332	establish	establish	B-VP	VBP	O	1	SBAR	O
O	O	O	333	340	latency	latency	B-NP	NN	O	4	OBJ	O
O	O	O	341	343	in	in	B-PP	IN	O	4	VMOD	O
O	O	O	344	353	quiescent	quiescent	B-NP	JJ	O	14	NMOD	O
O	O	O	354	359	human	human	I-NP	JJ	O	14	NMOD	O
O	O	O	359	360	-	-	I-NP	HYPH	O	14	NMOD	O
O	O	O	360	370	peripheral	peripheral	I-NP	JJ	B-cell_type	14	NMOD	B-cell_type
O	O	O	370	371	-	-	I-NP	HYPH	I-cell_type	14	NMOD	I-cell_type
O	O	O	371	376	blood	blood	I-NP	NN	I-cell_type	14	NMOD	I-cell_type
O	O	O	377	378	T	T	I-NP	NN	I-cell_type	14	NMOD	I-cell_type
O	O	O	379	384	cells	cell	I-NP	NNS	I-cell_type	6	PMOD	I-cell_type
O	O	O	384	385	,	,	O	,	O	24	P	O
O	O	O	386	389	the	the	B-NP	DT	O	18	NMOD	O
O	O	O	390	402	asymptomatic	asymptomatic	I-NP	JJ	O	18	NMOD	O
O	O	O	403	408	phase	phase	I-NP	NN	O	23	NMOD	O
O	O	O	409	411	of	of	B-PP	IN	O	18	NMOD	O
O	O	O	412	415	HIV	HIV	B-NP	NN	O	19	PMOD	O
O	O	O	415	416	-	-	O	HYPH	O	23	P	O
O	O	O	416	417	2	2	B-NP	CD	O	23	NMOD	O
O	O	O	418	427	infection	infection	I-NP	NN	O	24	SUB	O
O	O	O	428	431	may	may	B-VP	MD	O	0	ROOT	O
O	O	O	432	434	be	be	I-VP	VB	O	24	VC	O
O	O	O	435	439	more	more	B-ADJP	RBR	O	27	AMOD	O
O	O	O	440	449	prolonged	prolonged	I-ADJP	JJ	O	25	PRD	O
O	O	O	450	454	than	than	B-PP	IN	O	27	AMOD	O
O	O	O	455	459	that	that	B-NP	DT	O	28	PMOD	O
O	O	O	460	462	of	of	B-PP	IN	O	29	NMOD	O
O	O	O	463	466	HIV	HIV	B-NP	NN	O	30	PMOD	O
O	O	O	466	467	-	-	B-NP	HYPH	O	31	P	O
O	O	O	467	468	1	1	I-NP	CD	O	31	NMOD	O
O	O	O	468	469	.	.	O	.	O	24	P	O

O	O	O	470	473	The	The	B-NP	DT	O	3	NMOD	O
O	O	O	474	480	latent	latent	I-NP	JJ	O	3	NMOD	O
O	O	O	481	487	phases	phase	I-NP	NNS	O	14	SUB	O
O	O	O	488	490	of	of	B-PP	IN	O	3	NMOD	O
O	O	O	491	495	both	both	O	CC	O	13	NMOD	O
O	O	O	496	499	HIV	HIV	B-NP	NN	O	13	NMOD	O
O	O	O	499	500	-	-	B-NP	HYPH	O	13	NMOD	O
O	O	O	500	501	1	1	I-NP	CD	O	13	NMOD	O
O	O	O	502	505	and	and	I-NP	CC	O	13	NMOD	O
O	O	O	506	509	HIV	HIV	I-NP	NN	O	13	NMOD	O
O	O	O	509	510	-	-	I-NP	HYPH	O	13	NMOD	O
O	O	O	510	511	2	2	I-NP	CD	O	13	NMOD	O
O	O	O	512	521	infection	infection	I-NP	NN	O	4	PMOD	O
O	O	O	522	526	have	have	B-VP	VBP	O	0	ROOT	O
O	O	O	527	531	been	be	I-VP	VBN	O	14	VC	O
O	O	O	532	537	shown	show	I-VP	VBN	O	15	VC	O
O	O	O	538	540	to	to	I-VP	TO	O	18	VMOD	O
O	O	O	541	543	be	be	I-VP	VB	O	16	VMOD	O
O	O	O	544	553	disrupted	disrupt	I-VP	VBN	O	18	VC	O
O	O	O	554	556	by	by	B-PP	IN	O	19	VMOD	O
O	O	O	557	558	T	T	B-NP	NN	O	24	NMOD	O
O	O	O	558	559	-	-	I-NP	HYPH	O	24	NMOD	O
O	O	O	559	563	cell	cell	I-NP	NN	O	24	NMOD	O
O	O	O	564	574	activation	activation	I-NP	NN	O	27	NMOD	O
O	O	O	574	575	,	,	O	,	O	27	P	O
O	O	O	576	577	a	a	B-NP	DT	O	27	NMOD	O
O	O	O	578	585	process	process	I-NP	NN	O	20	PMOD	O
O	O	O	586	590	that	that	B-NP	WDT	O	27	NMOD	O
O	O	O	591	599	requires	require	B-VP	VBZ	O	28	SBAR	O
O	O	O	600	604	host	host	B-NP	NN	O	33	NMOD	O
O	O	O	605	609	cell	cell	I-NP	NN	O	33	NMOD	O
O	O	O	610	623	transcription	transcription	I-NP	NN	O	33	NMOD	O
O	O	O	624	631	factors	factor	I-NP	NNS	O	29	OBJ	O
O	O	O	631	632	.	.	O	.	O	14	P	O

O	O	O	633	635	In	In	B-PP	IN	O	16	VMOD	O
O	O	O	636	639	the	the	B-NP	DT	O	3	NMOD	O
O	O	O	640	644	case	case	I-NP	NN	O	1	PMOD	O
O	O	O	645	647	of	of	B-PP	IN	O	3	NMOD	O
O	O	O	648	651	HIV	HIV	B-NP	NN	O	4	PMOD	O
O	O	O	651	652	-	-	B-NP	HYPH	O	5	P	O
O	O	O	652	653	1	1	I-NP	CD	O	5	NMOD	O
O	O	O	653	654	,	,	O	,	O	16	P	O
O	O	O	655	658	the	the	B-NP	DT	O	11	NMOD	O
O	O	O	659	672	transcription	transcription	I-NP	NN	B-protein	11	NMOD	B-protein
O	O	O	673	679	factor	factor	I-NP	NN	I-protein	15	NMOD	I-protein
T8	B-Entity	B-Entity	680	682	NF	NF	I-NP	NN	B-protein	15	NMOD	B-protein
T8	I-Entity	I-Entity	682	683	-	-	B-NP	HYPH	I-protein	15	NMOD	I-protein
T8	I-Entity	I-Entity	683	688	kappa	kappa	I-NP	NN	I-protein	15	NMOD	I-protein
T8	I-Entity	I-Entity	689	690	B	B	I-NP	NN	I-protein	16	SUB	I-protein
O	O	O	691	693	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	694	704	sufficient	sufficient	B-ADJP	JJ	O	16	PRD	O
O	O	O	705	708	for	for	B-PP	IN	O	17	AMOD	O
O	O	O	709	718	inducible	inducible	B-NP	JJ	O	21	NMOD	O
O	O	O	719	734	transcriptional	transcriptional	I-NP	JJ	O	21	NMOD	O
O	O	O	735	745	activation	activation	I-NP	NN	O	18	PMOD	O
O	O	O	745	746	.	.	O	.	O	16	P	O

O	O	O	747	749	In	In	B-PP	IN	O	12	VMOD	O
O	O	O	750	758	contrast	contrast	B-NP	NN	O	1	PMOD	O
O	O	O	758	759	,	,	O	,	O	12	P	O
O	O	O	760	767	factors	factor	B-NP	NNS	O	12	SUB	O
O	O	O	768	770	in	in	B-PP	IN	O	4	NMOD	O
O	O	O	771	779	addition	addition	B-NP	NN	O	5	PMOD	O
O	O	O	780	782	to	to	B-PP	TO	O	6	NMOD	O
T9	B-Entity	B-Entity	783	785	NF	NF	B-NP	NN	B-protein	11	NMOD	B-protein
T9	I-Entity	I-Entity	785	786	-	-	B-NP	HYPH	I-protein	11	NMOD	I-protein
T9	I-Entity	I-Entity	786	791	kappa	kappa	I-NP	NN	I-protein	11	NMOD	I-protein
T9	I-Entity	I-Entity	792	793	B	B	I-NP	NN	I-protein	7	PMOD	I-protein
O	O	O	794	797	are	be	B-VP	VBP	O	0	ROOT	O
O	O	O	798	806	required	require	I-VP	VBN	O	12	VC	O
O	O	O	807	809	to	to	I-VP	TO	O	15	VMOD	O
O	O	O	810	818	activate	activate	I-VP	VB	O	13	VMOD	O
O	O	O	819	822	HIV	HIV	B-NP	NN	O	19	NMOD	O
O	O	O	822	823	-	-	B-NP	HYPH	O	19	NMOD	O
O	O	O	823	824	2	2	I-NP	CD	O	19	NMOD	O
O	O	O	825	838	transcription	transcription	I-NP	NN	O	15	OBJ	O
O	O	O	839	841	in	in	B-PP	IN	O	19	NMOD	O
O	O	O	842	850	infected	infected	B-NP	JJ	B-cell_type	23	NMOD	B-cell_type
O	O	O	851	852	T	T	I-NP	NN	I-cell_type	23	NMOD	I-cell_type
O	O	O	853	858	cells	cell	I-NP	NNS	I-cell_type	20	PMOD	I-cell_type
O	O	O	858	859	.	.	O	.	O	12	P	O

O	O	O	860	862	In	In	B-PP	IN	O	6	VMOD	O
O	O	O	863	867	this	this	B-NP	DT	O	3	NMOD	O
O	O	O	868	874	report	report	I-NP	NN	O	1	PMOD	O
O	O	O	874	875	,	,	O	,	O	6	P	O
O	O	O	876	878	we	we	B-NP	PRP	O	6	SUB	O
O	O	O	879	890	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT	O
O	O	O	891	895	that	that	B-SBAR	IN	O	6	VMOD	O
O	O	O	896	897	a	a	B-NP	DT	O	14	NMOD	O
O	O	O	898	903	novel	novel	I-NP	JJ	O	14	NMOD	O
T10	B-Entity	B-Entity	904	907	Ets	Ets	I-NP	NN	B-protein	14	NMOD	B-protein
O	O	O	907	908	-	-	B-NP	HYPH	O	14	NMOD	O
O	O	O	908	915	related	relate	I-NP	VBN	O	14	NMOD	O
O	O	O	916	929	transcription	transcription	I-NP	NN	B-protein	14	NMOD	B-protein
O	O	O	930	936	factor	factor	I-NP	NN	I-protein	17	NMOD	I-protein
O	O	O	936	937	,	,	O	,	O	17	P	O
T2	B-Protein	B-Protein	938	941	Elf	Elf	B-NP	NN	B-protein	17	NMOD	B-protein
T2	I-Protein	I-Protein	941	942	-	-	B-NP	HYPH	I-protein	20	SUB	I-protein
T2	I-Protein	I-Protein	942	943	1	1	I-NP	CD	I-protein	17	NMOD	I-protein
O	O	O	943	944	,	,	O	,	O	17	P	O
O	O	O	945	950	binds	bind	B-VP	VBZ	O	7	SBAR	O
O	O	O	951	963	specifically	specifically	B-ADVP	RB	O	20	VMOD	O
O	O	O	964	966	to	to	B-PP	TO	O	20	VMOD	O
O	O	O	967	970	two	two	B-NP	CD	O	27	NMOD	O
T11	B-Entity	B-Entity	971	977	purine	purine	I-NP	NN	B-DNA	27	NMOD	B-DNA
T11	I-Entity	I-Entity	977	978	-	-	B-NP	HYPH	I-DNA	27	NMOD	I-DNA
T11	I-Entity	I-Entity	978	982	rich	rich	I-NP	JJ	I-DNA	27	NMOD	I-DNA
T11	I-Entity	I-Entity	983	989	motifs	motif	I-NP	NNS	I-DNA	22	PMOD	I-DNA
O	O	O	990	992	in	in	B-PP	IN	O	27	NMOD	O
O	O	O	993	996	the	the	B-NP	DT	O	33	NMOD	O
T12	B-Entity	B-Entity	997	1000	HIV	HIV	I-NP	NN	B-DNA	33	NMOD	B-DNA
T12	I-Entity	I-Entity	1000	1001	-	-	B-NP	HYPH	I-DNA	33	NMOD	I-DNA
T12	I-Entity	I-Entity	1001	1002	2	2	I-NP	CD	I-DNA	33	NMOD	I-DNA
T12	I-Entity	I-Entity	1003	1011	enhancer	enhancer	I-NP	NN	I-DNA	28	PMOD	I-DNA
O	O	O	1011	1012	.	.	O	.	O	6	P	O

O	O	O	1013	1024	Mutagenesis	Mutagenesis	B-NP	NN	O	2	NMOD	O
O	O	O	1025	1036	experiments	experiment	I-NP	NNS	O	3	SUB	O
O	O	O	1037	1049	demonstrated	demonstrate	B-VP	VBD	O	0	ROOT	O
O	O	O	1050	1054	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	O	1055	1060	these	these	B-NP	DT	O	6	NMOD	O
T3	B-Protein	B-Protein	1061	1064	Elf	Elf	I-NP	NN	B-protein	10	NMOD	B-protein
T3	I-Protein	I-Protein	1064	1065	-	-	B-NP	HYPH	O	10	NMOD	O
T3	I-Protein	I-Protein	1065	1066	1	1	I-NP	CD	B-DNA	10	NMOD	B-DNA
T13	B-Entity	B-Entity	1067	1074	binding	bind	I-NP	VBG	I-DNA	10	NMOD	I-DNA
T13	I-Entity	I-Entity	1075	1080	sites	site	I-NP	NNS	I-DNA	11	SUB	I-DNA
O	O	O	1081	1084	are	be	B-VP	VBP	O	4	SBAR	O
O	O	O	1085	1093	required	require	I-VP	VBN	O	11	VC	O
O	O	O	1094	1097	for	for	B-PP	IN	O	12	VMOD	O
O	O	O	1098	1107	induction	induction	B-NP	NN	O	19	NMOD	O
O	O	O	1108	1110	of	of	B-PP	IN	O	14	NMOD	O
O	O	O	1111	1114	HIV	HIV	B-NP	NN	O	15	PMOD	O
O	O	O	1114	1115	-	-	O	HYPH	O	19	P	O
O	O	O	1115	1116	2	2	B-NP	CD	O	19	NMOD	O
O	O	O	1117	1130	transcription	transcription	I-NP	NN	O	13	PMOD	O
O	O	O	1131	1140	following	follow	B-PP	VBG	O	19	NMOD	O
O	O	O	1141	1142	T	T	B-NP	NN	B-protein	25	NMOD	B-protein
O	O	O	1142	1143	-	-	B-NP	HYPH	I-protein	25	P	I-protein
O	O	O	1143	1147	cell	cell	I-NP	NN	I-protein	25	NMOD	I-protein
O	O	O	1147	1148	-	-	B-NP	HYPH	I-protein	25	P	I-protein
O	O	O	1148	1156	receptor	receptor	I-NP	NN	I-protein	31	NMOD	I-protein
O	O	O	1156	1157	-	-	B-NP	HYPH	O	31	NMOD	O
O	O	O	1157	1165	mediated	mediate	I-NP	VBN	O	31	NMOD	O
O	O	O	1166	1167	T	T	I-NP	NN	O	31	NMOD	O
O	O	O	1167	1168	-	-	I-NP	HYPH	O	31	NMOD	O
O	O	O	1168	1172	cell	cell	I-NP	NN	O	31	NMOD	O
O	O	O	1173	1183	activation	activation	I-NP	NN	O	20	PMOD	O
O	O	O	1183	1184	.	.	O	.	O	3	P	O

O	O	O	1185	1193	Moreover	Moreover	B-ADVP	RB	O	6	VMOD	O
O	O	O	1193	1194	,	,	O	,	O	6	P	O
T4	B-Protein	B-Protein	1195	1198	Elf	Elf	B-NP	NN	B-protein	4	NMOD	B-protein
T4	I-Protein	I-Protein	1198	1199	-	-	B-NP	HYPH	I-protein	6	SUB	I-protein
T4	I-Protein	I-Protein	1199	1200	1	1	I-NP	CD	I-protein	4	NMOD	I-protein
O	O	O	1201	1203	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	1204	1207	the	the	B-NP	DT	O	9	NMOD	O
O	O	O	1208	1212	only	only	I-NP	JJ	O	9	NMOD	O
O	O	O	1213	1219	factor	factor	I-NP	NN	O	6	PRD	O
O	O	O	1220	1227	present	present	B-ADJP	JJ	O	9	NMOD	O
O	O	O	1228	1230	in	in	B-PP	IN	O	10	AMOD	O
O	O	O	1231	1240	activated	activate	B-NP	VBN	O	17	NMOD	O
O	O	O	1241	1242	T	T	I-NP	NN	O	17	NMOD	O
O	O	O	1242	1243	-	-	I-NP	HYPH	O	17	P	O
O	O	O	1243	1247	cell	cell	I-NP	NN	O	17	NMOD	O
O	O	O	1248	1255	nuclear	nuclear	I-NP	JJ	O	17	NMOD	O
O	O	O	1256	1264	extracts	extract	I-NP	NNS	O	11	PMOD	O
O	O	O	1265	1269	that	that	B-NP	WDT	O	9	NMOD	O
O	O	O	1270	1275	binds	bind	B-VP	VBZ	O	18	SBAR	O
O	O	O	1276	1278	to	to	B-PP	TO	O	19	VMOD	O
O	O	O	1279	1284	these	these	B-NP	DT	O	22	NMOD	O
O	O	O	1285	1290	sites	site	I-NP	NNS	O	20	PMOD	O
O	O	O	1291	1293	in	in	B-PP	IN	O	19	VMOD	O
O	O	O	1294	1309	electrophoretic	electrophoretic	B-NP	JJ	O	27	NMOD	O
O	O	O	1310	1318	mobility	mobility	I-NP	NN	O	27	NMOD	O
O	O	O	1319	1324	shift	shift	I-NP	NN	O	27	NMOD	O
O	O	O	1325	1331	assays	assay	I-NP	NNS	O	23	PMOD	O
O	O	O	1331	1332	.	.	O	.	O	6	P	O

O	O	O	1333	1337	Thus	Thus	B-ADVP	RB	O	6	VMOD	O
O	O	O	1337	1338	,	,	O	,	O	6	P	O
T5	B-Protein	B-Protein	1339	1342	Elf	Elf	B-NP	NN	B-protein	4	NMOD	B-protein
T5	I-Protein	I-Protein	1342	1343	-	-	B-NP	HYPH	I-protein	6	SUB	I-protein
T5	I-Protein	I-Protein	1343	1344	1	1	I-NP	CD	I-protein	4	NMOD	I-protein
O	O	O	1345	1347	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	1348	1349	a	a	B-NP	DT	O	10	NMOD	O
O	O	O	1350	1355	novel	novel	I-NP	JJ	O	10	NMOD	O
O	O	O	1356	1369	transcription	transcription	I-NP	NN	B-protein	10	NMOD	B-protein
O	O	O	1370	1376	factor	factor	I-NP	NN	I-protein	6	PRD	I-protein
O	O	O	1377	1381	that	that	B-NP	WDT	O	10	NMOD	O
O	O	O	1382	1389	appears	appear	B-VP	VBZ	O	11	SBAR	O
O	O	O	1390	1392	to	to	I-VP	TO	O	14	VMOD	O
O	O	O	1393	1395	be	be	I-VP	VB	O	12	VMOD	O
O	O	O	1396	1404	required	require	I-VP	VBN	O	14	VC	O
O	O	O	1405	1408	for	for	B-PP	IN	O	15	VMOD	O
O	O	O	1409	1412	the	the	B-NP	DT	O	22	NMOD	O
O	O	O	1413	1414	T	T	I-NP	NN	B-protein	22	NMOD	B-protein
O	O	O	1414	1415	-	-	B-NP	HYPH	I-protein	22	P	I-protein
O	O	O	1415	1419	cell	cell	I-NP	NN	I-protein	22	NMOD	I-protein
O	O	O	1419	1420	-	-	B-NP	HYPH	I-protein	22	P	I-protein
O	O	O	1420	1428	receptor	receptor	I-NP	NN	I-protein	26	NMOD	I-protein
O	O	O	1428	1429	-	-	O	HYPH	O	22	P	O
O	O	O	1429	1437	mediated	mediate	B-VP	VBN	O	22	AMOD	O
O	O	O	1438	1443	trans	trans	B-NP	JJ	O	22	NMOD	O
O	O	O	1444	1454	activation	activation	I-NP	NN	O	16	PMOD	O
O	O	O	1455	1457	of	of	B-PP	IN	O	26	NMOD	O
T14	B-Entity	B-Entity	1458	1461	HIV	HIV	B-NP	NN	B-DNA	31	NMOD	B-DNA
T14	I-Entity	I-Entity	1461	1462	-	-	B-NP	HYPH	I-DNA	31	NMOD	I-DNA
T14	I-Entity	I-Entity	1462	1463	2	2	I-NP	CD	I-DNA	31	NMOD	I-DNA
T14	I-Entity	I-Entity	1464	1468	gene	gene	I-NP	NN	I-DNA	32	NMOD	I-DNA
O	O	O	1469	1479	expression	expression	I-NP	NN	O	27	PMOD	O
O	O	O	1479	1480	.	.	O	.	O	6	P	O

O	O	O	1481	1486	These	These	B-NP	DT	O	2	NMOD	O
O	O	O	1487	1494	results	result	I-NP	NNS	O	3	SUB	O
O	O	O	1495	1498	may	may	B-VP	MD	O	0	ROOT	O
O	O	O	1499	1506	explain	explain	I-VP	VB	O	3	VC	O
O	O	O	1507	1518	differences	difference	B-NP	NNS	O	4	OBJ	O
O	O	O	1519	1521	in	in	B-PP	IN	O	5	NMOD	O
O	O	O	1522	1525	the	the	B-NP	DT	O	9	NMOD	O
O	O	O	1526	1534	clinical	clinical	I-NP	JJ	O	9	NMOD	O
O	O	O	1535	1542	spectra	spectrum	I-NP	NNS	O	6	PMOD	O
O	O	O	1543	1545	of	of	B-PP	IN	O	9	NMOD	O
O	O	O	1546	1554	diseases	disease	B-NP	NNS	O	10	PMOD	O
O	O	O	1555	1561	caused	cause	B-VP	VBN	O	11	NMOD	O
O	O	O	1562	1564	by	by	B-PP	IN	O	12	VMOD	O
O	O	O	1565	1568	HIV	HIV	B-NP	NN	O	13	PMOD	O
O	O	O	1568	1569	-	-	B-NP	HYPH	O	14	NMOD	O
O	O	O	1569	1570	1	1	I-NP	CD	O	15	OBJ	O
O	O	O	1571	1574	and	and	I-NP	CC	O	16	NMOD	O
O	O	O	1575	1578	HIV	HIV	I-NP	NN	O	17	OBJ	O
O	O	O	1578	1579	-	-	B-NP	HYPH	O	18	NMOD	O
O	O	O	1579	1580	2	2	I-NP	CD	O	19	OBJ	O
O	O	O	1581	1584	and	and	O	CC	O	3	VMOD	O
O	O	O	1585	1588	may	may	B-VP	MD	O	3	VMOD	O
O	O	O	1589	1593	also	also	I-VP	RB	O	22	VMOD	O
O	O	O	1594	1598	have	have	I-VP	VB	O	22	VC	O
O	O	O	1599	1611	implications	implication	B-NP	NNS	O	24	OBJ	O
O	O	O	1612	1615	for	for	B-PP	IN	O	25	NMOD	O
O	O	O	1616	1619	the	the	B-NP	DT	O	28	NMOD	O
O	O	O	1620	1626	design	design	I-NP	NN	O	26	PMOD	O
O	O	O	1627	1629	of	of	B-PP	IN	O	28	NMOD	O
O	O	O	1630	1641	therapeutic	therapeutic	B-NP	JJ	O	31	NMOD	O
O	O	O	1642	1652	approaches	approach	I-NP	NNS	O	29	PMOD	O
O	O	O	1653	1655	to	to	B-PP	TO	O	31	NMOD	O
O	O	O	1656	1659	HIV	HIV	B-NP	NN	O	36	NMOD	O
O	O	O	1659	1660	-	-	O	HYPH	O	36	NMOD	O
O	O	O	1660	1661	2	2	B-NP	CD	O	36	NMOD	O
O	O	O	1662	1671	infection	infection	I-NP	NN	O	32	PMOD	O
O	O	O	1671	1672	.	.	O	.	O	3	P	O
